12-08-2026 17:55 via drugs.com

Deramiocel Can Safely Slow Progression in Advanced Duchenne Muscular Dystrophy

WEDNESDAY, Aug. 12, 2026-- Deramiocel, a heart-derived cellular therapy consisting of human allogeneic cardiosphere-derived cells, can safely slow progression of advanced Duchenne muscular dystrophy (DMD), according to a study published online...

Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay

First Metatarsophalangeal Joint Arthrodesis Eases Painful Hallux Rigidus

Menopausal Hormone Therapy Use Linked to Lower Risk for Alzheimer Disease

Study IDs Neurobiological Roots of Sensory Over-Responsivity

2005 to 2023 Saw Decrease in DXA Testing for Osteoporosis Screening

Rare Bacteria In Coastal Waters Has Killed 7 This Summer

Endometriosis Tied to Higher Risk for Developing Type 2 Diabetes

Older Adults Limit Movements With Rising Temperatures

Therapeutic Hypothermia Duration Explored in Comatose OHCA Survivors

Socializing: A Prescription For Healthier Brain Aging

Taking The Stairs May Lower Your Risk Of Dying From Heart Disease

Sweet Tooth? It Could Be Shaping Your Decisions, Study Says

Gambling Linked To Mental Health Problems Among College Students

Stressed Parents Turn To Screens For Help, Study Finds

Desktop versie

Deramiocel Can Safely Slow Progression in Advanced Duchenne Muscular Dystrophy

Pharmaceutical news